BRCA2 and cancer: The decreased BRCA1 and BRCA2 expression in this cell line are mainly due to its aggressive phenotype and defective DNA repair mechanism, which ultimately contribute to genomic instability, an important hallmark of cancer progression and therapeutic resistance (Katheeja et al. 2023).